Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre, Retrospective Chart Review Study to Characterise Gefitinib Usage and Outcomes in Routine Treatment

NCT01818947 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01818947
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01818947 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre, Retrospective Chart Review Study to Characterise Gefitinib Usage and Outcomes in Routine Treatment
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
June 30, 2013
Completion date
November 30, 2013
Enrollment
157 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer